Cargando…
The 9L(LUC)/Wistar rat glioma model is not suitable for immunotherapy☆
The availability of a well-characterized animal brain tumor model will play an important role in identifying treatments for human brain tumors. Wistar rats bearing 9L glioma cells can develop solid, well-circumcised tumors, and may be a useful animal model for the evaluation of various therapeutic a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308791/ https://www.ncbi.nlm.nih.gov/pubmed/25657674 http://dx.doi.org/10.3969/j.issn.1673-5374.2012.18.007 |
_version_ | 1782354585801719808 |
---|---|
author | Yang, Liping Zhao, Jingxiang Zhou, Guihong Wang, Yunfang Li, Lusi Yuan, Hongfeng Nan, Xue Guan, Lidong Pei, Xuetao |
author_facet | Yang, Liping Zhao, Jingxiang Zhou, Guihong Wang, Yunfang Li, Lusi Yuan, Hongfeng Nan, Xue Guan, Lidong Pei, Xuetao |
author_sort | Yang, Liping |
collection | PubMed |
description | The availability of a well-characterized animal brain tumor model will play an important role in identifying treatments for human brain tumors. Wistar rats bearing 9L glioma cells can develop solid, well-circumcised tumors, and may be a useful animal model for the evaluation of various therapeutic approaches for gliosarcomas. In this study, the 9L/Wistar rat glioma model was produced by intracerebral implantation of 9L(LUC) glioma cells syngenic to Fischer 344 (F344) rats. Bioluminescence imaging showed that tumors progressively grew from day 7 to day 21 in 9L(LUC)/F344 rats, and tumor regression was found in some 9L(LUC)/Wistar rats. Hematoxylin-eosin staining verified that intracranial tumors were gliomas. Immunohistochemistry results demonstrated that no CD(4)- and CD(8)-positive cells were found in the syngeneic 9L(LUC)/F344 model. However, many infiltrating CD(4)- and CD(8)-positive cells were observed within the tumors of the 9L(LUC)/Wistar model. Our data suggests that compared with 9L/F344 rats, 9L glioma Wistar rats may not be suitable for evaluating brain glioma immunotherapies, even though the model induced an immune response and exhibited tumor regression. |
format | Online Article Text |
id | pubmed-4308791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-43087912015-02-05 The 9L(LUC)/Wistar rat glioma model is not suitable for immunotherapy☆ Yang, Liping Zhao, Jingxiang Zhou, Guihong Wang, Yunfang Li, Lusi Yuan, Hongfeng Nan, Xue Guan, Lidong Pei, Xuetao Neural Regen Res Techniques and Method: Emerging Technology in Neural Regeneration The availability of a well-characterized animal brain tumor model will play an important role in identifying treatments for human brain tumors. Wistar rats bearing 9L glioma cells can develop solid, well-circumcised tumors, and may be a useful animal model for the evaluation of various therapeutic approaches for gliosarcomas. In this study, the 9L/Wistar rat glioma model was produced by intracerebral implantation of 9L(LUC) glioma cells syngenic to Fischer 344 (F344) rats. Bioluminescence imaging showed that tumors progressively grew from day 7 to day 21 in 9L(LUC)/F344 rats, and tumor regression was found in some 9L(LUC)/Wistar rats. Hematoxylin-eosin staining verified that intracranial tumors were gliomas. Immunohistochemistry results demonstrated that no CD(4)- and CD(8)-positive cells were found in the syngeneic 9L(LUC)/F344 model. However, many infiltrating CD(4)- and CD(8)-positive cells were observed within the tumors of the 9L(LUC)/Wistar model. Our data suggests that compared with 9L/F344 rats, 9L glioma Wistar rats may not be suitable for evaluating brain glioma immunotherapies, even though the model induced an immune response and exhibited tumor regression. Medknow Publications & Media Pvt Ltd 2012-06-25 /pmc/articles/PMC4308791/ /pubmed/25657674 http://dx.doi.org/10.3969/j.issn.1673-5374.2012.18.007 Text en Copyright: © Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Techniques and Method: Emerging Technology in Neural Regeneration Yang, Liping Zhao, Jingxiang Zhou, Guihong Wang, Yunfang Li, Lusi Yuan, Hongfeng Nan, Xue Guan, Lidong Pei, Xuetao The 9L(LUC)/Wistar rat glioma model is not suitable for immunotherapy☆ |
title | The 9L(LUC)/Wistar rat glioma model is not suitable for immunotherapy☆ |
title_full | The 9L(LUC)/Wistar rat glioma model is not suitable for immunotherapy☆ |
title_fullStr | The 9L(LUC)/Wistar rat glioma model is not suitable for immunotherapy☆ |
title_full_unstemmed | The 9L(LUC)/Wistar rat glioma model is not suitable for immunotherapy☆ |
title_short | The 9L(LUC)/Wistar rat glioma model is not suitable for immunotherapy☆ |
title_sort | 9l(luc)/wistar rat glioma model is not suitable for immunotherapy☆ |
topic | Techniques and Method: Emerging Technology in Neural Regeneration |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308791/ https://www.ncbi.nlm.nih.gov/pubmed/25657674 http://dx.doi.org/10.3969/j.issn.1673-5374.2012.18.007 |
work_keys_str_mv | AT yangliping the9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT zhaojingxiang the9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT zhouguihong the9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT wangyunfang the9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT lilusi the9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT yuanhongfeng the9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT nanxue the9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT guanlidong the9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT peixuetao the9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT yangliping 9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT zhaojingxiang 9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT zhouguihong 9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT wangyunfang 9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT lilusi 9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT yuanhongfeng 9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT nanxue 9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT guanlidong 9llucwistarratgliomamodelisnotsuitableforimmunotherapy AT peixuetao 9llucwistarratgliomamodelisnotsuitableforimmunotherapy |